FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169758210> ?p ?o ?g. }

• W2169758210 endingPage "4761" @default.
• W2169758210 startingPage "4755" @default.
• W2169758210 abstract "Purpose In a previous analysis of 326 children with Philadelphia chromosome (Ph) –positive acute lymphoblastic leukemia (ALL) treated between 1986 and 1996, hematopoietic stem-cell transplantation from HLA-matched related donors, but not from unrelated donors, offered a superior outcome than chemotherapy alone. To evaluate the impact of recent improvements in chemotherapy and transplantation, we performed a similar analysis on patients treated in the following decade. Patients and Methods We analyzed 610 patients with Ph-positive ALL treated between 1995 and 2005 without tyrosine kinase inhibitor therapy. The median follow-up duration was 6.3 years. Results Complete remission was achieved in 89% of patients. The 7-year event-free survival and overall survival rates were superior in the present cohort compared with the previous cohort (32.0% ± 2.0% v 25.0% ± 3.0, respectively, P = .007; and 44.9% ± 2.2% v 36.0% ± 3.0%, respectively, P = .017). Compared with chemotherapy alone, transplantation with matched related donors or unrelated donors in first remission (325 patients) showed an advantage with increasing follow-up, suggesting greater protection against late relapses (hazard ratio at 5 years, 0.37; P < .001). In the multivariate Cox regression analysis accounting for treatment (transplantation v no transplantation), age, leukocyte count, and early response had independent impact on treatment outcome. Conclusion Clinical outcome of children and adolescents with Ph-positive ALL has improved with advances in transplantation and chemotherapy. Transplantations with matched related donors and unrelated donors were equivalent and offered better disease control compared with chemotherapy alone. Age, leukocyte count, and early treatment response were independent prognostic indicators. The results of this study will serve as a historical reference to evaluate the therapeutic impact of tyrosine kinase inhibitors on the outcome of Ph-positive ALL." @default.
• W2169758210 created "2016-06-24" @default.
• W2169758210 creator A5000288435 @default.
• W2169758210 creator A5018536511 @default.
• W2169758210 creator A5019098042 @default.
• W2169758210 creator A5020812442 @default.
• W2169758210 creator A5022986622 @default.
• W2169758210 creator A5023214494 @default.
• W2169758210 creator A5023346779 @default.
• W2169758210 creator A5035292815 @default.
• W2169758210 creator A5036614366 @default.
• W2169758210 creator A5040079244 @default.
• W2169758210 creator A5048748466 @default.
• W2169758210 creator A5053476959 @default.
• W2169758210 creator A5070232314 @default.
• W2169758210 creator A5070351551 @default.
• W2169758210 creator A5080485119 @default.
• W2169758210 creator A5082007290 @default.
• W2169758210 creator A5083575870 @default.
• W2169758210 date "2010-11-01" @default.
• W2169758210 modified "2023-10-07" @default.
• W2169758210 title "Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005" @default.
• W2169758210 cites W1490840859 @default.
• W2169758210 cites W1532255091 @default.
• W2169758210 cites W1968013647 @default.
• W2169758210 cites W1972467214 @default.
• W2169758210 cites W1973248441 @default.
• W2169758210 cites W1976897003 @default.
• W2169758210 cites W1978709366 @default.
• W2169758210 cites W1979259896 @default.
• W2169758210 cites W1994053739 @default.
• W2169758210 cites W2001905425 @default.
• W2169758210 cites W2025671957 @default.
• W2169758210 cites W2028104399 @default.
• W2169758210 cites W2032639427 @default.
• W2169758210 cites W2053754416 @default.
• W2169758210 cites W2057388030 @default.
• W2169758210 cites W2058058260 @default.
• W2169758210 cites W2058572211 @default.
• W2169758210 cites W2061418833 @default.
• W2169758210 cites W2071818770 @default.
• W2169758210 cites W2096336184 @default.
• W2169758210 cites W2105608321 @default.
• W2169758210 cites W2119967034 @default.
• W2169758210 cites W2129291628 @default.
• W2169758210 cites W2148631711 @default.
• W2169758210 cites W2149646900 @default.
• W2169758210 cites W2151069914 @default.
• W2169758210 cites W2171403571 @default.
• W2169758210 cites W2254222484 @default.
• W2169758210 cites W8223099 @default.
• W2169758210 doi "https://doi.org/10.1200/jco.2010.30.1325" @default.
• W2169758210 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3020705" @default.
• W2169758210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20876426" @default.
• W2169758210 hasPublicationYear "2010" @default.
• W2169758210 type Work @default.
• W2169758210 sameAs 2169758210 @default.
• W2169758210 citedByCount "204" @default.
• W2169758210 countsByYear W21697582102012 @default.
• W2169758210 countsByYear W21697582102013 @default.
• W2169758210 countsByYear W21697582102014 @default.
• W2169758210 countsByYear W21697582102015 @default.
• W2169758210 countsByYear W21697582102016 @default.
• W2169758210 countsByYear W21697582102017 @default.
• W2169758210 countsByYear W21697582102018 @default.
• W2169758210 countsByYear W21697582102019 @default.
• W2169758210 countsByYear W21697582102020 @default.
• W2169758210 countsByYear W21697582102021 @default.
• W2169758210 countsByYear W21697582102022 @default.
• W2169758210 countsByYear W21697582102023 @default.
• W2169758210 crossrefType "journal-article" @default.
• W2169758210 hasAuthorship W2169758210A5000288435 @default.
• W2169758210 hasAuthorship W2169758210A5018536511 @default.
• W2169758210 hasAuthorship W2169758210A5019098042 @default.
• W2169758210 hasAuthorship W2169758210A5020812442 @default.
• W2169758210 hasAuthorship W2169758210A5022986622 @default.
• W2169758210 hasAuthorship W2169758210A5023214494 @default.
• W2169758210 hasAuthorship W2169758210A5023346779 @default.
• W2169758210 hasAuthorship W2169758210A5035292815 @default.
• W2169758210 hasAuthorship W2169758210A5036614366 @default.
• W2169758210 hasAuthorship W2169758210A5040079244 @default.
• W2169758210 hasAuthorship W2169758210A5048748466 @default.
• W2169758210 hasAuthorship W2169758210A5053476959 @default.
• W2169758210 hasAuthorship W2169758210A5070232314 @default.
• W2169758210 hasAuthorship W2169758210A5070351551 @default.
• W2169758210 hasAuthorship W2169758210A5080485119 @default.
• W2169758210 hasAuthorship W2169758210A5082007290 @default.
• W2169758210 hasAuthorship W2169758210A5083575870 @default.
• W2169758210 hasBestOaLocation W21697582102 @default.
• W2169758210 hasConcept C104317684 @default.
• W2169758210 hasConcept C126322002 @default.
• W2169758210 hasConcept C138626823 @default.
• W2169758210 hasConcept C141071460 @default.
• W2169758210 hasConcept C143998085 @default.
• W2169758210 hasConcept C185592680 @default.
• W2169758210 hasConcept C207103383 @default.
• W2169758210 hasConcept C2776694085 @default.
• W2169758210 hasConcept C2777408962 @default.

• next